Atlas Trials

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

Clinical trial NCT03352739 · UNKNOWN

Trial details

NCT number
NCT03352739
Sponsor
Xuanwu Hospital, Beijing
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2017-12-01
Primary completion
2019-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.